| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kabir Nath | CEO | 2026-08-03 | 5,962 | $11.25 | $67.07kSell |
| Teri Loxam | Chief Financial Officer | 2026-03-11 | 1,781 | $6.89 | $12.27kSell |
| Kabir Nath | Chief Executive Officer | 2026-03-11 | 13,131 | $6.89 | $90.47kSell |
| Teri Loxam | Chief Financial Officer | 2026-03-02 | 4,467 | $7.02 | $31.36kSell |
| Kabir Nath | Chief Executive Officer | 2026-02-02 | 16,181 | $6.61 | $106.96kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ekaterina Malievskaia | 7.47% | 10,592,171 | $90.99M | Insider |
| George Jay Goldsmith | 7.46% | 10,576,167 | $90.85M | Insider |
| Life Sciences Nv Atai | 4.87% | 6,905,774 | $59.32M | Insider |
| Kabir Nath | 0.25% | 361,028 | $3.10M | Insider |
| Teri Loxam | 0.11% | 152,002 | $1.31M | Insider |
| Thomas Lonngren | 0.06% | 89,049 | $764.93k | Insider |
| Matthew A. Owens | 0.03% | 43,340 | $372.29k | Insider |
| Michael Falvey | 0.02% | 22,500 | $193.28k | Insider |
| David Y. Norton | 0.01% | 20,356 | $174.86k | Insider |
| Annalisa Jenkins | 0.01% | 19,480 | $167.33k | Insider |